A.R.T. Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-20,677	Closed	-$41K	–	185
2020 Q2	$41K	Buy	+20,677	New	+$40.5K	0.06%	233
2019 Q2	–	Sell	-48,152	Closed	-$268K	–	1513
2019 Q1	$268K	Buy	+48,152	New	+$293K	0.02%	980
2018 Q4	–	Sell	-28,200	Closed	-$300K	–	1518
2018 Q3	$300K	Sell	28,200 -14,600	-34%	-$167K	0.01%	1037
2018 Q2	$513K	Sell	42,800 -11,466	-21%	-$117K	0.02%	910
2018 Q1	$465K	Buy	54,266 +22,533	+71%	+$208K	0.02%	987
2017 Q4	$313K	Buy	+31,733	New	+$330K	0.01%	1046
2017 Q3	–	Sell	-34,400	Closed	-$565K	–	1521
2017 Q2	$565K	Buy	34,400 +9,700	+39%	+$150K	0.03%	749
2017 Q1	$354K	Sell	24,700 -9,700	-28%	-$144K	0.02%	936
2016 Q4	$475K	Buy	+34,400	New	+$552K	0.03%	772
2016 Q2	–	Sell	-14,574	Closed	-$174K	–	1511
2016 Q1	$174K	Buy	+14,574	New	+$153K	0.01%	1200
2014 Q2	–	Sell	-18,519	Closed	-$224K	–	1432
2014 Q1	$224K	Sell	18,519 -57	-0.3%	-$728	0.01%	1115
2013 Q4	$234K	Buy	18,576 +2,367	+15%	+$37.7K	0.01%	1059
2013 Q3	$270K	Hold	16,209	–	–	0.01%	1018
2013 Q2	$246K	Buy	+16,209	New	+$246K	0.01%	1104